Justin Chakma

Justin Chakma is a life sciences venture capital investor with Thomas, McNerney & Partners in La Jolla, CA. He has published over 20 articles in peer-reviewed journals on healthcare policy and innovation, including the New England Journal of Medicine.

Recent posts

U.S. Biomedical Research at a Precipice
[Editor’s Note: this post was co-authored by Justin Chakma, Dr. Reshma Jagsi, and Stephen M. Sammut.]
Since 1950, U.S. government funding has supported research underlying 84 percent of Nobel... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

And the 2020 National Xconomy Awards Winners Are...

Tau-Targeting Alzheimer’s Drug from AC Immune, Roche Fails in Phase 2

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function”

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor

Xcelerating Life Sciences New York

Justin Chakma

Recent posts

U.S. Biomedical Research at a Precipice

Underwriters and Partners

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

How Big Is the US Market for Medical Devices & Technologies?

Xconomy on Demand

We offer a number of ways to subscribe for free!